High-level human herpesvirus-6 viremia associated with onset of Stevens-Johnson syndrome: report of two cases
- PMID: 20182379
- PMCID: PMC4396637
- DOI: 10.1097/BCR.0b013e3181d0f48b
High-level human herpesvirus-6 viremia associated with onset of Stevens-Johnson syndrome: report of two cases
Abstract
The pathogenesis of Stevens-Johnson syndrome (SJS) remains obscure, but it has been associated with various infectious agents, including members of the herpesvirus family. We present the first report of high-level human herpesvirus-6 viremia at the onset of SJS, suggesting a possible new association. This finding supports the need for further investigation into the possible relationship between human herpesvirus-6 and SJS, which may illuminate the pathogenesis of SJS and bring us closer to achieving enhanced prevention and treatment of this rare disease.
Conflict of interest statement
Conflicts of interest: no conflicts for any of the authors
Figures

Similar articles
-
A case of toxic epidermal necrolysis induced by allopurinol with human herpesvirus-6 reactivation.Acta Derm Venereol. 2013 Nov;93(6):731-2. doi: 10.2340/00015555-1610. Acta Derm Venereol. 2013. PMID: 23604033 No abstract available.
-
Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.Allergol Int. 2016 Jan;65(1):74-81. doi: 10.1016/j.alit.2015.09.001. Epub 2015 Oct 9. Allergol Int. 2016. PMID: 26666483
-
Intravenous immunoglobulins for the management of Stevens-Johnson syndrome with minimal skin manifestations.Eur J Pediatr. 2007 Jun;166(6):585-8. doi: 10.1007/s00431-006-0287-9. Epub 2006 Sep 29. Eur J Pediatr. 2007. PMID: 17008995
-
Efficacy and safety of cyclosporine in Stevens-Johnson syndrome and toxic epidermal necrolysis.Dermatol Ther. 2019 Jan;32(1):e12758. doi: 10.1111/dth.12758. Epub 2018 Oct 30. Dermatol Ther. 2019. PMID: 30285308 Review.
-
Intravenous immunoglobulin use in patients with toxic epidermal necrolysis and Stevens-Johnson syndrome.Am J Clin Dermatol. 2006;7(6):359-68. doi: 10.2165/00128071-200607060-00004. Am J Clin Dermatol. 2006. PMID: 17173470 Review.
Cited by
-
The Link between Hypersensitivity Syndrome Reaction Development and Human Herpes Virus-6 Reactivation.Int J Hepatol. 2012;2012:723062. doi: 10.1155/2012/723062. Epub 2012 May 16. Int J Hepatol. 2012. PMID: 22666603 Free PMC article.
-
Severe drug eruptions revisited.Immunol Res. 2012 Sep;53(1-3):162-7. doi: 10.1007/s12026-012-8271-0. Immunol Res. 2012. PMID: 22407574 Review.
-
Stevens-Johnson syndrome/toxic epidermal necrolysis associated with zonisamide.Clin Case Rep. 2017 Dec 20;6(2):258-261. doi: 10.1002/ccr3.1288. eCollection 2018 Feb. Clin Case Rep. 2017. PMID: 29445458 Free PMC article.
-
Recent advances in the understanding of severe cutaneous adverse reactions.Br J Dermatol. 2017 Nov;177(5):1234-1247. doi: 10.1111/bjd.15423. Epub 2017 Sep 29. Br J Dermatol. 2017. PMID: 28256714 Free PMC article. Review.
-
Activation of human herpesvirus replication by apoptosis.J Virol. 2013 Oct;87(19):10641-50. doi: 10.1128/JVI.01178-13. Epub 2013 Jul 24. J Virol. 2013. PMID: 23885073 Free PMC article.
References
-
- Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol. 1993;129:92–6. - PubMed
-
- Roujeau JC, Huynh TN, Bracq C, Guillaume JC, Revuz J, Touraine R. Genetic susceptibility to toxic epidermal necrolysis. Arch Dermatol. 1987;123:1171–3. - PubMed
-
- Choy AC, Arnold PR, Brown JE, Kayaloglou GT, Greenberger PA, Patterson R. Virus induced Erythema Multiforme and Stevens-Johnson syndrome. Allergy Proc. 1995;16:157–61. - PubMed
-
- Detjen PF, Patterson R, Noskin GA, Phair JP, Loyd SO. Herpes simplex virus associated with recurrent Stevens-Johnson syndrome. A management strategy. Arch Intern Med. 1992;152:1513–6. - PubMed
-
- Wanner M, Pol-Rodriguez M, Hinds G, Hutt C, Husain S, Grossman ME. Persistent erythema multiforme and CMV infection. J Drugs Dermatol. 2007;6:333–6. - PubMed